|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q41119951
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000227.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q41119951
|
|
024
|
|
|
‡a
0000-0002-4153-2543
‡2
orcid
|
|
024
|
|
|
‡a
7006728734
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q41119951
|
|
100
|
0 |
|
‡a
Jesús Devesa
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Jesús Devesa
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A 12-kilodalton N-glycosylated growth hormone-related peptide is present in human pituitary extracts
|
|
670
|
|
|
‡a
Author's A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
|
|
670
|
|
|
‡a
Author's Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway
|
|
670
|
|
|
‡a
Author's Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53.
|
|
670
|
|
|
‡a
Author's Adrenal cortex and type II polycystic ovary syndrome
|
|
670
|
|
|
‡a
Author's Alpha 2-adrenergic agonism enhances the growth hormone
|
|
670
|
|
|
‡a
Author's Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
|
|
670
|
|
|
‡a
Author's Atropine selectively blocks GHRH-induced GH secretion without altering LH, FSH, TSH, PRL and ACTH/cortisol secretion elicited by their specific hypothalamic releasing factors
|
|
670
|
|
|
‡a
Author's Clonidine potentiates the growth hormone
|
|
670
|
|
|
‡a
Author's Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin
|
|
670
|
|
|
‡a
Author's Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats
|
|
670
|
|
|
‡a
Author's Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.
|
|
670
|
|
|
‡a
Author's Correlation of Pit-1 gene expression and Pit-1 content with proliferation and differentiation in human myeloid leukemic cells
|
|
670
|
|
|
‡a
Author's Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man
|
|
670
|
|
|
‡a
Author's Dopamine acts on acetylation of proopiomelanocortin-derived products in dog pituitary
|
|
670
|
|
|
‡a
Author's Early growth hormone
|
|
670
|
|
|
‡a
Author's Early growth hormone (GH) treatment promotes relevant motor functional improvement after severe frontal cortex lesion in adult rats.
|
|
670
|
|
|
‡a
Author's [Effect of bromocrytine on the secretion of thyrotropic hormone and growth hormone
|
|
670
|
|
|
‡a
Author's Effect of bromocrytine on the secretion of thyrotropic hormone and growth hormone (author's transl)
|
|
670
|
|
|
‡a
Author's [Effect of cranio-spinal radiotherapy on growth]
|
|
670
|
|
|
‡a
Author's Effects of bromocriptine on pituitary and adrenal cortex in pre-adrenarchal rabbits
|
|
670
|
|
|
‡a
Author's Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
|
|
670
|
|
|
‡a
Author's Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy
|
|
670
|
|
|
‡a
Author's Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone,
|
|
670
|
|
|
‡a
Author's Expression of the human growth hormone normal gene (hGH-N) in proliferating and differentiated HL-60 cells.
|
|
670
|
|
|
‡a
Author's Factors Involved in the Functional Motor Recovery of Rats with Cortical Ablation after GH and Rehabilitation Treatment: Cortical Cell Proliferation and Nestin and Actin Expression in the Striatum and Thalamus
|
|
670
|
|
|
‡a
Author's Glucocorticoid deficiency with achalasia of the cardia and lack of lacrimation
|
|
670
|
|
|
‡a
Author's Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons
|
|
670
|
|
|
‡a
Author's Growth Hormone
|
|
670
|
|
|
‡a
Author's Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers
|
|
670
|
|
|
‡a
Author's Growth Hormone and the Auditory Pathway: Neuromodulation and Neuroregeneration
|
|
670
|
|
|
‡a
Author's Growth hormone deficiency and cerebral palsy
|
|
670
|
|
|
‡a
Author's Growth Hormone (GH) and Cardiovascular System
|
|
670
|
|
|
‡a
Author's Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade
|
|
670
|
|
|
‡a
Author's Hypothyroidism is associated with increased myostatin expression in rats.
|
|
670
|
|
|
‡a
Author's Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary
|
|
670
|
|
|
‡a
Author's Metabolic and hormonal parameters after insulin-induced hypoglycemia in man, comparison between biosynthetic human insulin and purified pork insulin
|
|
670
|
|
|
‡a
Author's Morphological and functional stimulation of adrenal reticularis zone by dopaminergic blockade in dogs
|
|
670
|
|
|
‡a
Author's Motor Improvement of Skilled Forelimb Use Induced by Treatment with Growth Hormone and Rehabilitation Is Dependent on the Onset of the Treatment after Cortical Ablation.
|
|
670
|
|
|
‡a
Author's Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?
|
|
670
|
|
|
‡a
Author's Muscle myostatin expression in children with muscle diseases
|
|
670
|
|
|
‡a
Author's Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
|
|
670
|
|
|
‡a
Author's Myostatin expression is regulated by underfeeding and neonatal programming in rats.
|
|
670
|
|
|
‡a
Author's Myostatin is an inhibitor of myogenic differentiation.
|
|
670
|
|
|
‡a
Author's N-glycosylated variants of growth hormone in human pituitary extracts
|
|
670
|
|
|
‡a
Author's Neuroendocrine control of growth hormone secretion in humans
|
|
670
|
|
|
‡a
Author's [Neuroendocrine dysfunction caused by radiotherapy]
|
|
670
|
|
|
‡a
Author's Pattern of presentation of the human growth hormone variant
|
|
670
|
|
|
‡a
Author's Pattern of presentation of the human growth hormone variant (hGH-V) gene in the normal population
|
|
670
|
|
|
‡a
Author's Proteolytic processing of human growth hormone
|
|
670
|
|
|
‡a
Author's Proteolytic processing of human growth hormone (GH) by rat tissues in vitro: influence of sex and age.
|
|
670
|
|
|
‡a
Author's Reasons for the variability in growth hormone
|
|
670
|
|
|
‡a
Author's Reasons for the variability in growth hormone (GH) responses to GHRH challenge: the endogenous hypothalamic-somatotroph rhythm (HSR)
|
|
670
|
|
|
‡a
Author's Regulation of hypothalamic somatostatin by glucocorticoids
|
|
670
|
|
|
‡a
Author's Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: studies with metoclopramide
|
|
670
|
|
|
‡a
Author's Studies on alpha 2-adrenergic modulation of hypothalamic somatostatin secretion in rats
|
|
670
|
|
|
‡a
Author's Study of the source
|
|
670
|
|
|
‡a
Author's Study of the source(s) of hyperandrogenism in women with idiopathic hirsutism
|
|
670
|
|
|
‡a
Author's Synergistic effect of growth hormone-releasing hormone
|
|
670
|
|
|
‡a
Author's Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs.
|
|
670
|
|
|
‡a
Author's The control of GH secretion by GHRH and somatostatin: the current status
|
|
670
|
|
|
‡a
Author's The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
|
|
670
|
|
|
‡a
Author's The role of sexual steroids in the modulation of growth hormone
|
|
670
|
|
|
‡a
Author's The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans.
|
|
670
|
|
|
‡a
Author's Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era
|
|
670
|
|
|
‡a
Author's Treatment with Growth Hormone (GH) Increased the Metabolic Activity of the Brain in an Elder Patient, Not GH-Deficient, Who Suffered Mild Cognitive Alterations and Had an ApoE 4/3 Genotype
|
|
909
|
|
|
‡a
(orcid) 0000000241532543
‡9
1
|
|
909
|
|
|
‡a
(scopus) 7006728734
‡9
1
|
|
919
|
|
|
‡a
pentosephosphatepathwaydynamicsincanceranditsdependencyonintracellularph
‡A
The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
‡9
1
|
|
919
|
|
|
‡a
controlofghsecretionbyghrhandsomatostatinthecurrentstatus
‡A
The control of GH secretion by GHRH and somatostatin: the current status
‡9
1
|
|
919
|
|
|
‡a
synergisticeffectofgrowthhormonereleasinghormoneghrhandclonidineinstimulatingghreleaseinyoungandolddogs
‡A
Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs.
‡9
1
|
|
919
|
|
|
‡a
synergisticeffectofgrowthhormonereleasinghormone
‡A
Synergistic effect of growth hormone-releasing hormone
‡9
1
|
|
919
|
|
|
‡a
studyofthesourcesofhyperandrogenisminwomenwithidiopathichirsutism
‡A
Study of the source(s) of hyperandrogenism in women with idiopathic hirsutism
‡9
1
|
|
919
|
|
|
‡a
studyofthesource
‡A
Study of the source
‡9
1
|
|
919
|
|
|
‡a
studiesonalpha2adrenergicmodulationofhypothalamicsomatostatinsecretioninrats
‡A
Studies on alpha 2-adrenergic modulation of hypothalamic somatostatin secretion in rats
‡9
1
|
|
919
|
|
|
‡a
roleofcentraldopaminergicpathwaysintheneuralcontrolofgrowthhormonesecretioninnormalmenstudieswithmetoclopramide
‡A
Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: studies with metoclopramide
‡9
1
|
|
919
|
|
|
‡a
regulationofhypothalamicsomatostatinbyglucocorticoids
‡A
Regulation of hypothalamic somatostatin by glucocorticoids
‡9
1
|
|
919
|
|
|
‡a
reasonsforthevariabilityingrowthhormoneghresponsestoghrhchallengetheendogenoushypothalamicsomatotrophrhythmhsr
‡A
Reasons for the variability in growth hormone (GH) responses to GHRH challenge: the endogenous hypothalamic-somatotroph rhythm (HSR)
‡9
1
|
|
919
|
|
|
‡a
reasonsforthevariabilityingrowthhormone
‡A
Reasons for the variability in growth hormone
‡9
1
|
|
919
|
|
|
‡a
proteolyticprocessingofhumangrowthhormone
‡A
Proteolytic processing of human growth hormone
‡9
1
|
|
919
|
|
|
‡a
patternofpresentationofthehumangrowthhormonevarianthgh5geneinthenormalpopulation
‡A
Pattern of presentation of the human growth hormone variant (hGH-V) gene in the normal population
‡9
1
|
|
919
|
|
|
‡a
patternofpresentationofthehumangrowthhormonevariant
‡A
Pattern of presentation of the human growth hormone variant
‡9
1
|
|
919
|
|
|
‡a
neuroendocrinedysfunctioncausedbyradiotherapy
‡A
[Neuroendocrine dysfunction caused by radiotherapy]
‡9
1
|
|
919
|
|
|
‡a
neuroendocrinecontrolofgrowthhormonesecretioninhumans
‡A
Neuroendocrine control of growth hormone secretion in humans
‡9
1
|
|
919
|
|
|
‡a
nglycosylatedvariantsofgrowthhormoneinhumanpituitaryextracts
‡A
N-glycosylated variants of growth hormone in human pituitary extracts
‡9
1
|
|
919
|
|
|
‡a
myostatinisaninhibitorofmyogenicdifferentiation
‡A
Myostatin is an inhibitor of myogenic differentiation.
‡9
1
|
|
919
|
|
|
‡a
myostatinexpressionisregulatedbyunderfeedingandneonatalprogramminginrats
‡A
Myostatin expression is regulated by underfeeding and neonatal programming in rats.
‡9
1
|
|
919
|
|
|
‡a
myostatinexpressioninmusculardystrophiesandmitochondrialencephalomyopathies
‡A
Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
‡9
1
|
|
919
|
|
|
‡a
musclemyostatinexpressioninchildrenwithmusclediseases
‡A
Muscle myostatin expression in children with muscle diseases
‡9
1
|
|
919
|
|
|
‡a
multipleeffectsofgrowthhormoneinthebodyisitreallythehormoneforgrowth
‡A
Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?
‡9
1
|
|
919
|
|
|
‡a
motorimprovementofskilledforelimbuseinducedbytreatmentwithgrowthhormoneandrehabilitationisdependentontheonsetofthetreatmentaftercorticalablation
‡A
Motor Improvement of Skilled Forelimb Use Induced by Treatment with Growth Hormone and Rehabilitation Is Dependent on the Onset of the Treatment after Cortical Ablation.
‡9
1
|
|
919
|
|
|
‡a
morphologicalandfunctionalstimulationofadrenalreticulariszonebydopaminergicblockadeindogs
‡A
Morphological and functional stimulation of adrenal reticularis zone by dopaminergic blockade in dogs
‡9
1
|
|
919
|
|
|
‡a
metabolicandhormonalparametersafterinsulininducedhypoglycemiainmancomparisonbetweenbiosynthetichumaninsulinandpurifiedporkinsulin
‡A
Metabolic and hormonal parameters after insulin-induced hypoglycemia in man, comparison between biosynthetic human insulin and purified pork insulin
‡9
1
|
|
919
|
|
|
‡a
inhibitoryeffectofcabergolineonthedevelopmentofestrogeninducedprolactinsecretingadenomasofthepituitary
‡A
Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary
‡9
1
|
|
919
|
|
|
‡a
hypothyroidismisassociatedwithincreasedmyostatinexpressioninrats
‡A
Hypothyroidism is associated with increased myostatin expression in rats.
‡9
1
|
|
919
|
|
|
‡a
growthhormoneghresponsivenesstoghrhinnormaladultsisnotaffectedbyshorttermgonadalblockade
‡A
Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade
‡9
1
|
|
919
|
|
|
‡a
growthhormoneghandcardiovascularsystem
‡A
Growth Hormone (GH) and Cardiovascular System
‡9
1
|
|
919
|
|
|
‡a
growthhormonedeficiencyandcerebralpalsy
‡A
Growth hormone deficiency and cerebral palsy
‡9
1
|
|
919
|
|
|
‡a
atropineselectivelyblocksghrhinducedghsecretionwithoutalteringlhfshtshprlandacthcortisolsecretionelicitedbytheirspecifichypothalamicreleasingfactors
‡A
Atropine selectively blocks GHRH-induced GH secretion without altering LH, FSH, TSH, PRL and ACTH/cortisol secretion elicited by their specific hypothalamic releasing factors
‡9
1
|
|
919
|
|
|
‡a
growthhormoneandprolactinsecretionaftergrowthhormonereleasinghormoneadministrationinanorexianervosapatientsnormalcontrolsandtamoxifenpretreatedvolunteers
‡A
Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers
‡9
1
|
|
919
|
|
|
‡a
growthhormone
‡A
Growth Hormone
‡9
1
|
|
919
|
|
|
‡a
glucocorticoidsmayinhibitgrowthhormonereleasebyenhancingbetaadrenergicresponsivenessinhypothalamicsomatostatinneurons
‡A
Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons
‡9
1
|
|
919
|
|
|
‡a
glucocorticoiddeficiencywithachalasiaofthecardiaandlackoflacrimation
‡A
Glucocorticoid deficiency with achalasia of the cardia and lack of lacrimation
‡9
1
|
|
919
|
|
|
‡a
factorsinvolvedinthefunctionalmotorrecoveryofratswithcorticalablationafterghandrehabilitationtreatmentcorticalcellproliferationandnestinandactinexpressioninthestriatumandthalamus
‡A
Factors Involved in the Functional Motor Recovery of Rats with Cortical Ablation after GH and Rehabilitation Treatment: Cortical Cell Proliferation and Nestin and Actin Expression in the Striatum and Thalamus
‡9
1
|
|
919
|
|
|
‡a
expressionofthehumangrowthhormonenormalgenehghninproliferatinganddifferentiatedhl60cells
‡A
Expression of the human growth hormone normal gene (hGH-N) in proliferating and differentiated HL-60 cells.
‡9
1
|
|
919
|
|
|
‡a
alpha2adrenergicagonismenhancesthegrowthhormoneghresponsetoghreleasinghormonethroughaninhibitionofhypothalamicsomatostatinreleaseinnormalmen
‡A
Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
‡9
1
|
|
919
|
|
|
‡a
evidencethatalpha2adrenergicpathwaysplayamajorroleingrowthhormoneghneuroregulationalpha2adrenergicagonismcounteractstheinhibitoryeffectofmuscariniccholinergicreceptorblockadeontheghresponsetoghreleasinghormone
‡A
Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone,
‡9
1
|
|
919
|
|
|
‡a
effectsofrecombinantgrowthhormonereplacementandphysicalrehabilitationinrecoveryofgrossmotorfunctioninchildrenwithcerebralpalsy
‡A
Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy
‡9
1
|
|
919
|
|
|
‡a
effectsofrecombinantgrowthhormoneghreplacementandpsychomotorandcognitivestimulationintheneurodevelopmentofghdeficientghdchildrenwithcerebralpalsyapilotstudy
‡A
Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
‡9
1
|
|
919
|
|
|
‡a
effectsofbromocriptineonpituitaryandadrenalcortexinpreadrenarchalrabbits
‡A
Effects of bromocriptine on pituitary and adrenal cortex in pre-adrenarchal rabbits
‡9
1
|
|
919
|
|
|
‡a
alpha2adrenergicagonismenhancesthegrowthhormone
‡A
Alpha 2-adrenergic agonism enhances the growth hormone
‡9
1
|
|
919
|
|
|
‡a
effectofcraniospinalradiotherapyongrowth
‡A
[Effect of cranio-spinal radiotherapy on growth]
‡9
1
|
|
919
|
|
|
‡a
effectofbromocrytineonthesecretionofthyrotropichormoneandgrowthhormoneauthorstransl
‡A
Effect of bromocrytine on the secretion of thyrotropic hormone and growth hormone (author's transl)
‡9
1
|
|
919
|
|
|
‡a
effectofbromocrytineonthesecretionofthyrotropichormoneandgrowthhormone
‡A
[Effect of bromocrytine on the secretion of thyrotropic hormone and growth hormone
‡9
1
|
|
919
|
|
|
‡a
adrenalcortexandtype2polycysticovarysyndrome
‡A
Adrenal cortex and type II polycystic ovary syndrome
‡9
1
|
|
919
|
|
|
‡a
earlygrowthhormoneghtreatmentpromotesrelevantmotorfunctionalimprovementafterseverefrontalcortexlesioninadultrats
‡A
Early growth hormone (GH) treatment promotes relevant motor functional improvement after severe frontal cortex lesion in adult rats.
‡9
1
|
|
919
|
|
|
‡a
earlygrowthhormone
‡A
Early growth hormone
‡9
1
|
|
919
|
|
|
‡a
12kilodaltonnglycosylatedgrowthhormonerelatedpeptideispresentinhumanpituitaryextracts
‡A
A 12-kilodalton N-glycosylated growth hormone-related peptide is present in human pituitary extracts
‡9
1
|
|
919
|
|
|
‡a
dopamineactsonacetylationofproopiomelanocortinderivedproductsindogpituitary
‡A
Dopamine acts on acetylation of proopiomelanocortin-derived products in dog pituitary
‡9
1
|
|
919
|
|
|
‡a
dependingonthetimeofadministrationdexamethasonepotentiatesorblocksgrowthhormonereleasinghormoneinducedgrowthhormonereleaseinman
‡A
Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man
‡9
1
|
|
919
|
|
|
‡a
activationofhumansomatostatinreceptor2promotesapoptosisthroughamechanismthatisindependentfrominductionofp53
‡A
Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53.
‡9
1
|
|
919
|
|
|
‡a
correlationofpit1geneexpressionandpit1contentwithproliferationanddifferentiationinhumanmyeloidleukemiccells
‡A
Correlation of Pit-1 gene expression and Pit-1 content with proliferation and differentiation in human myeloid leukemic cells
‡9
1
|
|
919
|
|
|
‡a
clonidinepretreatmentmodifiesthegrowthhormonesecretorypatterninducedbyshorttermcontinuousgrfinfusioninnormalman
‡A
Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.
‡9
1
|
|
919
|
|
|
‡a
newandintegralapproachtotheetiopathogenesisandtreatmentofbreastcancerbaseduponitshydrogeniondynamics
‡A
A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
‡9
1
|
|
919
|
|
|
‡a
clonidinepotentiatesthegrowthhormoneresponsetoagrowthhormonereleasinghormonechallengeinhypothalamicgrowthhormonereleasinghormonedeficientrats
‡A
Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats
‡9
1
|
|
919
|
|
|
‡a
proteolyticprocessingofhumangrowthhormoneghbyrattissuesinvitroinfluenceofsexandage
‡A
Proteolytic processing of human growth hormone (GH) by rat tissues in vitro: influence of sex and age.
‡9
1
|
|
919
|
|
|
‡a
activationofgrowthhormonereceptordeliversanantiapoptoticsignalevidenceforaroleofaktinthispathway
‡A
Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway
‡9
1
|
|
919
|
|
|
‡a
clonidinepotentiatesthegrowthhormone
‡A
Clonidine potentiates the growth hormone
‡9
1
|
|
919
|
|
|
‡a
clonidinepotentiatesthegrowthhormoneghresponsetoghreleasinghormoneinnorepinephrinesynthesisinhibitedratsevidenceforanalpha2adrenergiccontrolofhypothalamicreleaseofsomatostatin
‡A
Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin
‡9
1
|
|
919
|
|
|
‡a
growthhormoneandtheauditorypathwayneuromodulationandneuroregeneration
‡A
Growth Hormone and the Auditory Pathway: Neuromodulation and Neuroregeneration
‡9
1
|
|
919
|
|
|
‡a
treatmentwithgrowthhormoneghincreasedthemetabolicactivityofthebraininanelderpatientnotghdeficientwhosufferedmildcognitivealterationsandhadanapoe43genotype
‡A
Treatment with Growth Hormone (GH) Increased the Metabolic Activity of the Brain in an Elder Patient, Not GH-Deficient, Who Suffered Mild Cognitive Alterations and Had an ApoE 4/3 Genotype
‡9
1
|
|
919
|
|
|
‡a
towardsanintegraltherapeuticprotocolforbreastcancerbaseduponthenewh+centeredanticancerparadigmofthelatepostwarburgera
‡A
Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era
‡9
1
|
|
919
|
|
|
‡a
roleofsexualsteroidsinthemodulationofgrowthhormoneghsecretioninhumans
‡A
The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans.
‡9
1
|
|
919
|
|
|
‡a
roleofsexualsteroidsinthemodulationofgrowthhormone
‡A
The role of sexual steroids in the modulation of growth hormone
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
BNE|XX5453296
|
|
996
|
|
|
‡2
ISNI|0000000060767570
|
|
996
|
|
|
‡2
BNC|981060723548606706
|
|
996
|
|
|
‡2
PTBNP|237496
|
|
996
|
|
|
‡2
ISNI|0000000070928884
|
|
996
|
|
|
‡2
RERO|A003176454
|
|
996
|
|
|
‡2
BNE|XX1623052
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
